Dengue Disease: Malacards - Research Articles, Symptoms, Drugs, Genes, Clinical Trials

Aliases & Classifications for Dengue Disease

Sources:
³²LifeMap Discovery®, ¹⁰Disease Ontology, ¹²DISEASES, ⁴⁵NIH Rare Diseases, ⁶⁵UMLS, ⁵¹Orphanet, ²CDC, ⁴⁷Novoseek, ³⁶MeSH, ³⁵MedlinePlus, ²⁷ICD10, ²⁹ICD9CM, ⁴²NCIt, ⁵⁹SNOMED-CT, ²⁸ICD10 via Orphanet, ³⁷MESH via Orphanet, ⁶⁶UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Dengue Disease:

Name: Dengue Disease ³² ¹⁰ ¹²

Dengue Fever ¹⁰ ⁴⁵ ⁵¹ ² ⁶⁵

Dengue ⁴⁷ ³⁶ ³⁵

Df ⁴⁵ ⁵¹ ²

Dengue Virus Infection ⁴⁵ ⁵¹

Dengue Shock Syndrome ⁴⁵ ⁶⁵

Philippine Hemorrhagic Fever ⁴⁵

Singapore Hemorrhagic Fever ⁴⁵

Dengue Hemorrhagic Fever ⁴⁵

Thai Hemorrhagic Fever ⁴⁵

Hemorrhagic Dengue ⁴⁵

Classical Dengue ¹⁰

Breakbone Fever ¹⁰

Classic Dengue ¹⁰

Severe Dengue ⁶⁵

Characteristics:

Orphanet epidemiological data:

⁵¹

dengue fever:
Prevalence: >1/1000 (Worldwide); Age of onset: All ages; Age of death: any age

Classifications:

MalaCards categories:
Global: Rare diseases, Infectious diseases

See all MalaCards categories (disease lists)

ICD10: ²⁸ ²⁷

Certain infectious and parasitic diseases

Arthropod-borne viral fevers and viral haemorrhagic fevers

Dengue fever [classical dengue]

Orphanet: ⁵¹

Rare infectious diseases

External Ids:

Disease Ontology¹⁰ DOID:12205

ICD10²⁷ A90

ICD9CM²⁹ 061

MeSH³⁶ D003715

NCIt⁴² C34528

SNOMED-CT⁵⁹ 154345006, 266194002, 38362002

Orphanet⁵¹ 99828

ICD10 via Orphanet²⁸ A97.0, A97.1, A97.2 A97.9, more

MESH via Orphanet³⁷ D003715

UMLS via Orphanet⁶⁶ C0011311

UMLS⁶⁵ C0011311, C0376300

Summaries for Dengue Disease

Sources:
¹⁰Disease Ontology, ³⁵MedlinePlus, ³³MalaCards
See all MalaCards sources

MedlinePlus:³⁵ Dengue is an infection caused by a virus. you can get it if an infected mosquito bites you. dengue does not spread from person to person. it is common in warm, wet areas of the world. outbreaks occur in the rainy season. dengue is rare in the united states. symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. in some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from your nose, gums, or under your skin. it can also become dengue shock syndrome, which causes massive bleeding and shock. these forms of dengue are life-threatening. there is no specific treatment. most people with dengue recover within 2 weeks. until then, drinking lots of fluids, resting and taking non-aspirin fever-reducing medicines might help. people with the more severe forms of dengue usually need to go to the hospital and get fluids. to lower your risk when traveling to areas where dengue is found wear insect repellent with deet wear clothes that cover your arms, legs and feet close unscreened doors and windows nih: national institute of allergy and infectious diseases

MalaCards based summary: Dengue Disease, also known as dengue fever, is related to thrombocytopenia and dengue hemorrhagic fever, and has symptoms including facial pain/cephalalgia/migraine, fever/chilling and cutaneous rash. An important gene associated with Dengue Disease is CD209 (CD209 Molecule), and among its related pathways are LDL Oxidation in Atherogenesis and CD209 (DC-SIGN) signaling. Affiliated tissues include eye, bone and skin, and related mouse phenotypes are hematopoietic system and immune system.

Disease Ontology:¹⁰ A viral infectious disease that results in infection, has material basis in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.

Related Diseases for Dengue Disease

Sources:
²⁰GeneCards, ¹⁹GeneAnalytics
See all MalaCards sources

Diseases related to Dengue Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)

id	Related Disease	Score	Top Affiliating Genes
1	thrombocytopenia	30.3	ICAM1, VCAM1
2	dengue hemorrhagic fever	23.1	CCL5, CD209, CD40LG, HCFC1, ICAM1, IVNS1ABP
3	dengue fever, protection against	12.3
4	erdheim-chester disease	10.7	CD209, CD40LG
5	plasma cell neoplasm	10.7	ICAM1, VCAM1
6	liver cirrhosis	10.7	ICAM1, VCAM1
7	rhizomelic dysplasia patterson lowry type	10.7	ICAM1, VCAM1
8	intestinal tuberculosis	10.7	CD209, CD40LG
9	immunotactoid glomerulopathy	10.7	CD40LG, MBL2
10	inferior myocardial infarction	10.6	ICAM1, VCAM1
11	renovascular hypertension	10.6	CD40LG, THPO
12	anogenital venereal wart	10.6	CD209, MRC1
13	splenic abscess	10.6	CD40LG, THPO
14	pemphigus	10.6	CD40LG, ICAM1
15	verrucous nevus acanthokeratolytic	10.5	CCL5, ICAM1
16	chlamydia	10.5	CD40LG, MRC1
17	angioedema	10.5	CD40LG, ICAM1
18	ureteral lymphoma	10.5	CD40LG, MRC1
19	schizophreniform disorder	10.5	CD40LG, RAF1
20	crescentic glomerulonephritis	10.5	CD40LG, ICAM1
21	conduct disorder	10.5	ICAM1, VCAM1
22	qualitative platelet defect	10.5	CD40LG, ICAM1, VCAM1
23	cauda equina syndrome	10.5	CD40LG, MBL2
24	oral pharyngeal disorders	10.5	CCL5, ICAM1, VCAM1
25	nuclear gene-encoded leigh syndrome	10.5	PTPN11, RAF1
26	western equine encephalitis	10.5	CD40LG, RAF1
27	eyelid degenerative disease	10.4	CCL5, ICAM1, VCAM1
28	hodgkin's granuloma	10.4	CD40LG, ICAM1, VCAM1
29	motion sickness	10.4	CCL5, CD209, MBL2
30	pseudoachondroplastic dysplasia 2	10.4	PTPN11, RAF1
31	immunoglobulin beta deficiency	10.4	CD40LG, MBL2
32	metachondromatosis	10.4	PTPN11, RAF1
33	rad21-related cornelia de lange syndrome	10.4	PTPN11, RAF1
34	colonic benign neoplasm	10.4	CCL5, ICAM1, VCAM1
35	urethral diverticulum	10.4	CCL5, CD209, CD40LG
36	babesiosis	10.4	CD40LG, PIK3C2A
37	motor peripheral neuropathy	10.4	CCL5, ICAM1
38	pharyngoconjunctival fever	10.3	CCL5, CD40LG
39	legionaire disease	10.3	CD40LG, PIK3C2A
40	aspartylglucosaminuria	10.3	CD209, CD40LG, MRC1
41	scleritis	10.3	CD40LG, MBL2, MRC1
42	neuroaxonal dystrophy	10.3	CD209, CD40LG, RAF1
43	immature teratoma of ovary	10.2	ICAM1, PIK3C2A, VCAM1
44	learning disability	10.2	CD40LG, THPO
45	keratinizing squamous cell carcinoma	10.1	CCL5, MBL2, PIK3C2A
46	mitochondrial metabolism disease	10.1	CD40LG, ICAM1, MRC1, VCAM1
47	meige syndrome	10.1	CD40LG, MRC1, PIK3C2A
48	pseudohypoaldosteronism, type iid	10.0	CCL5, ICAM1, VCAM1
49	multiple sclerosis, disease progression, modifier of	10.0	CCL5, ICAM1, VCAM1
50	diffuse scleroderma	10.0	CCL5, CD40LG, ICAM1, MRC1

Graphical network of the top 20 diseases related to Dengue Disease:

Symptoms for Dengue Disease

Sources:
⁵¹Orphanet, ¹⁰Disease Ontology, ⁶⁵UMLS
See all MalaCards sources

Symptoms:

⁵¹ ¹⁰ (show all 30)

facial pain/cephalalgia/migraine
fever/chilling
cutaneous rash
pruritus/itching
acute abdominal pain/colic
articular/joint pain/arthralgia
purpura/petichiae
ecchymoses
ascitis
nausea/vomiting/regurgitation/merycism/hyperemesis
acute diarrhea
gastrointestinal bleeding/hemorrhage/hematemesis/melena/rectorrhagia
hepatomegaly/liver enlargement (excluding storage disease)
collapse/sudden death/cardiac arrest/cardiorespiratory arrest
hypotension

obnubilation/coma/lethargia/desorientation
leukopenia/hypoleukocytosis
thrombocytopenia/thrombopenia
epistaxis/nose bleeding
gingivorrhagia/gingival bleeding
intracranial/cerebral/meningeal hemorrhage
hypoproteinemia
early death/lethality
fever
severe headache
severe pain behind the eyes
joint pain
muscle
rash
mild bleeding

UMLS symptoms related to Dengue Disease:

pruritus

Drugs & Therapeutics for Dengue Disease

Sources:
⁴⁴NIH Clinical Center, ⁴ClinicalTrials, ⁶Cochrane Library, ⁶⁵UMLS, ⁴³NDF-RT, ¹³DrugBank, ²⁶HMDB, ⁹DGIdb, ⁵³PharmGKB, ³⁰IUPHAR, ⁴⁷Novoseek, ¹BitterDB
See all MalaCards sources

Drugs for Dengue Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 59)

id

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Ketotifen

approved

Phase 4

21

34580-14-8

3827

Synonyms:

10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1)

116655-74-4

34580-13-7

4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one

4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one

4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one

4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one

4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one

AB00053575

AC-15945

AC1L1GSZ

AKOS000541268

Alaway

Alaway (TN)

Allergy Eye

Allergy Eye Drops

Allergy Eye original prescription strength

Allergy Relief Eye

Allergy Relief Eye Drops

Antihistamine Eye

BAS 00444483

BIDD:GT0509

BPBio1_000575

BRD-K28936863-051-05-8

BRN 3983897

BSPBio_000521

BSPBio_002964

C19H19NOS

CAS-34580-14-8

CHEBI:112957

CHEMBL534

CID3827

Care One Allergy Eye

Care One Eye Itch Relief

D08105

DB00920

DivK1c_000111

EINECS 252-099-7

Equaline Eye Itch Relief

Equate Eye Itch Relief

Equate Itchy Eye

Eye Itch

Eye Itch Relief

Good Neighbor Pharmacy Eye Itch Relief

Good Neighbor Pharmacy Itchy Eye

Good Sense Allergy Eye

Good Sense Eye Itch Relief

Good Sense Itchy Eye original prescription strength

HC 20-511

HMS2090F16

HSDB 7283

Health Mart Eye Itch Relief

IDI1_000111

Itchy Eye

Itchy Eye Drops

Itchy Eye Relief

Itchy Eye original prescription strength

KBio1_000111

KBio2_000906

KBio2_003474

KBio2_006042

KBio3_002184

KBioGR_001289

KBioSS_000906

Ketotifen (INN)

Ketotifen Fumarate

Ketotifen [INN:BAN]

Ketotifene

Ketotifene [INN-French]

Ketotifene fumarate

Ketotifeno

Ketotifeno [INN-Spanish]

Ketotifenum

Ketotifenum [INN-Latin]

Ketotifin

Ketotiphen

Ketotiphene

L000753

LS-33820

Leader Allergy Eye

Leader Eye Itch Relief Drops

Lopac-K-2628

Lopac0_000706

MolPort-001-933-278

NCGC00015580-01

NCGC00015580-02

NCGC00015580-03

NCGC00015580-09

NCGC00022572-02

NCGC00022572-04

NCGC00022572-05

NINDS_000111

Oprea1_335550

Oprea1_553550

Prestwick0_000371

Prestwick1_000371

Prestwick2_000371

Prestwick3_000371

SPBio_001275

SPBio_002442

STK048448

STOCK1S-14132

Smart Sense Allergy

Spectrum2_001198

Spectrum3_001382

Spectrum4_000805

Spectrum5_001395

Spectrum_000426

Sunmark Eye Itch Relief

Tocris-0784

Topcare Eye Itch Relief

UNII-X49220T18G

Wal Zyr

Zaditor

Zaditor Antihistamine Eye Drops

ketotifen

2

Histamine Phosphate

approved

Phase 4

906

51-74-1

65513

Synonyms:

1H-Imidazole-4-ethanamine, phosphate (1:2)

2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)

4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)

4-(2-Aminoethyl)imidazole di-acid phosphate

4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate

51-74-1

53623-99-7

74-56-6

AC1L23E4

CID65513

D04445

DB00667

EINECS 200-118-4

H0147

Histamine Positive Skin Test Control

Histamine Positive skin test control

Histamine acid phosphate

Histamine biphosphate

Histamine dihydrogen phosphate

Histamine diphosphate

Histamine phosphate (1:2)

Histamine phosphate (TN)

Histamine phosphate (USP)

Histamine phosphate [USP]

Histamine positive

Histaminum

LS-78569

UNII-QWB37T4WZZ

3

Immunologic Factors

Phase 4, Phase 3, Phase 2, Phase 1

18483

4

Vaccines

Phase 4, Phase 3, Phase 2, Phase 1

6085

5

Neurotransmitter Agents

Phase 4

14795

6

Anti-Allergic Agents

Phase 4

1312

7

Contraceptives, Oral

Phase 4

3734

8

Antipruritics

Phase 4

619

9

Dermatologic Agents

Phase 4

4555

10

Histamine Antagonists

Phase 4

826

11

histamine

Phase 4

906

75614-87-8, 51-45-6

774

Synonyms:

.beta.-Imidazolyl-4-ethylamine

1H-Imidazole-4-ethanamine

1H-Imidazole-5-ethanamine

1avn

1qft

2-(1H-Imidazol-4-yl)ethanamine

2-(1H-Imidazol-4-yl)ethylamine

2-(1H-Imidazol-5-yl)ethanamine

2-(1H-Imidazol-5-yl)ethylamine

2-(1H-imidazol-4-yl)ethan-1-amine

2-(1H-imidazol-5-yl)ethanamine

2-(3H-Imidazol-4-yl)-ethylamine

2-(4-Imidazolyl)ethanamine

2-(4-Imidazolyl)ethylamine

2-Imidazol-4-yl-Ethylamine

2-Imidazol-4-ylethylamine

2-[4-Imidazolyl]ethylamine

4-(2-Aminoethyl)-1H-imidazole

4-(2-Aminoethyl)imidazole

4-Imidazoleethylamine

5-Imidazoleethylamine

51-45-6

53290_FLUKA

64422-25-9

924364-91-0

AC-13185

AC1L19ZT

AC1Q54BV

AC1Q54BW

AKOS000274386

ALBB-005968

BCBcMAP01_000250

BSPBio_001117

BSPBio_002124

Bio1_000487

Bio1_000976

Bio1_001465

Bio2_000389

Bio2_000869

C00388

CCRIS 6535

CHEBI:18295

CHEMBL90

CID774

D08040

DivK1c_000308

EINECS 200-100-6

Eramin

Ergamine

Ergotidine

F411C768-A159-4FC0-A195-291A08BB03AA

Free histamine

H7125_SIGMA

HMS1362G19

HMS1792G19

HMS1990G19

HSDB 3338

HSM

Histamine

Histamine (DCF)

Histamine Base

Histamine [USAN]

Histamine, Free Base

Histaminum

Histaminum (TN)

IDI1_000308

IDI1_002144

Imidazole-4-ethylamine

Istamina

Istamina [Italian]

KBio1_000308

KBio2_000457

KBio2_001325

KBio2_003025

KBio2_003893

KBio2_005593

KBio2_006461

KBio3_000853

KBio3_000854

KBio3_001344

KBioGR_000457

KBioGR_001580

KBioSS_000457

KBioSS_001325

L-Histamin base

L-Histamine

L-histamine

L000292

LS-75835

Lopac-H-7250

Lopac0_000595

MLS000069447

MolPort-001-785-597

MolPort-002-042-264

NCGC00015513-01

NCGC00015513-08

NCGC00093371-02

NCGC00093371-03

NCGC00093371-04

NCGC00093371-05

NINDS_000308

NSC 33792

NSC33792

SDCCGMLS-0066601.P001

SMP1_000151

SMR000059091

SPBio_000729

ST073926

STK346752

STOCK5S-55669

Spectrum2_000665

Spectrum3_000452

Spectrum4_000960

Spectrum5_000796

Spectrum_000845

Theramine

UNII-820484N8I3

WLN: T5M CNJ D2Z

ZERO/004089

[3H]histamine

b-Imidazolyl-4-ethylamine

beta-Aminoethylglyoxaline

beta-Aminoethylimidazole

beta-Aminothethylglyoxaline

beta-Imidazolyl-4-ethylamine

beta-aminothethylglyoxaline

bmse000744

histamine

nchembio.87-comp54

nchembio714-comp1

12

Histamine H1 Antagonists

Phase 4

688

13

Ivermectin

approved

Phase 2, Phase 3

47

70288-86-7

6474909, 46936176

Synonyms:

(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside

22,23-Dihydroxy-avermectin B

22,23-Dihyroavermectin B1

5-O-Demethyl-22,23-dihydro-avermectin A1a

71827-03-7

AB00513813

AC1MJ4GR

AC1N7O27

BPBio1_000322

BRD-K24652731-001-02-7

BSPBio_000292

CHEMBL341047

CID11957587

CID4330618

CID6321424

CID6419971

CID6427057

EU-0100693

FT-0082656

HMS1568O14

HMS2089M09

I 8898

I8898_SIGMA

IVERMECTIN

Ivermectin

Ivermectina

Ivermectine

Ivermectinum

Lopac0_000693

MK-933

MLS001333247

MLS001333248

MLS002153248

MolPort-006-394-715

NCGC00094047-01

NCGC00094047-02

NCGC00094047-03

Prestwick2_000156

Prestwick3_000156

Prestwick_516

S1351_Selleck

SMR000857211

Sklice

Soolantra

Stromectol

14

Pharmaceutical Solutions

Phase 3, Phase 2, Phase 1

7004

15

Heptavalent Pneumococcal Conjugate Vaccine

Phase 3, Phase 2

440

16

Protective Agents

Phase 3

5651

17

Anti-Infective Agents

Phase 2, Phase 3, Phase 1

17220

18

Insect Repellents

Phase 3

2

19

Antiparasitic Agents

Phase 2, Phase 3, Phase 1

1854

20

Neomycin

approved

Phase 1, Phase 2

42

1404-04-2

8378

Synonyms:

(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside

(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol

11025-81-3

119-04-0

1393-86-8

1404-04-2

1405-10-3 (sulfate (salt))

4-18-00-07476 (Beilstein Handbook Reference)

72131_FLUKA

AB00443887

AC1L1QVH

Actilin

Actiline

Antibiotic 10676

Antibiotic produced by Streptomyces decaris. Neomycin B

Antibiotique

BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG

BDG-(1-4)NEB-(5-1)RIB-(3-1)NED

BPBio1_000326

BRN 0101621

BSPBio_000296

C01737

C23H46N6O13

C25H50N6O13

CCRIS 5462

CHEBI:7508

CID8378

Caswell No. 595

D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy

D05140

DB00452

DB00994

EINECS 204-292-2

EINECS 215-766-3

EPA Pesticide Chemical Code 006303

Endomixin

Enterfram

Fradiomycin

Fradiomycin B

Fradiomycinum

Framicetina

Framicetina [INN-Spanish]

Framycetin

Framycetin (INN)

Framycetin [INN:BAN:DCF]

Framycetine

Framycetine [INN-French]

Framycetinum

Framycetinum [INN-Latin]

Framygen

Fraquinol

HMS2089P15

HSDB 3242

LS-96091

LS-96095

MolPort-003-938-736

Myacine

Myacyne

Mycifradin

Myciguent

N1142_SIGMA

NCGC00179612-01

NEOMYCIN AND POLYMYXIN B SULFATES

NEOMYCIN B

NEOMYCIN SULFATE

NMY

Neo-Fradin

Neo-Rx

Neo-fradin

Neobiotic

Neobrettin

Neolate

Neomas

Neomcin

Neomicina

Neomicina [DCIT]

Neomin

Neomycin B Sulfate

Neomycin B sulfate

Neomycin Sulfate

Neomycin Sulphate

Neomycin solution

Neomycine

Neomycine [INN-French]

Neomycinum

Neomycinum [INN-Latin]

Nivemycin

PIMAVECORT

Prestwick3_000158

ST075177

Soframycin

Soframycin Ophthalmic

Soframycine

Theraplusplus Plus

Tuttomycin

UNII-4BOC774388

UNII-I16QD7X297

USAF CB-19

VONAMYCIN

Vonamycin powder V

neomycin

21

Hydrocortisone

approved

Phase 2

583

50-23-7

5754, 657311

Synonyms:

(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione

1 Hydrocortisone maximum strength

11-Hydrocortisone

11-beta-Hydrocortisone

11-beta-Hydroxycortisone

11a-Hydroxycorticosterone

11alpha-Hydroxycorticosterone

11b,17,21-Trihydroxyprogesterone

11b-Hydrocortisone

11b-Hydroxycortisone

11beta,17,21-Trihydroxyprogesterone

11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione

11beta-Hydrocortisone

11beta-Hydroxycortisone

11beta-hydrocortisone

11β-hydrocortisone

17-Hydroxycorticosterone

17a-Hydroxycorticosterone

17alpha-Hydroxycorticosterone

2v95

4-Pregnen-11beta,17alpha,21-triol-3,20-dione

4-Pregnene-11alpha,21-triol 3,20-dione

4-Pregnene-11b,17a,21-triol-3,20-dione

50-23-7

8056-08-4

80562-38-5

8063-42-1

999 Itch Relieving

A-hydrocort

AC-12902

AC1L1L2B

ACETASOL HC

ACETIC ACID W/ HYDROCORTISONE

AI3-25006

AKOS001582651

Acticort

Acticort (TN)

Advanced Hydrocortisone

Aeroseb HC

Aeroseb-HC

Ala-Cort

Ala-Scalp

Alacort

Algicirtis

Alphaderm

Amberin

Anflam

Anti Itch

Anti Itch maximum strength

Anti Itch maximum strength plus

Anti-inflammatory hormone

Anti-itch

Anti-itch Scalp Relief Maximum Strength

Anucort

Anucort-HC

Anusol HC

Anusol HC (TN)

Apres Peel Soothing Balm

Aquacort

Aquanil HC

Atopalm Maximum Strength Anti-itch

Atopalm Moisturizing Hydrocortisone

Aveeno Hydrocortisone Anti Itch

B48448A1-24BA-47CA-8D9E-43E5BC949386

BPBio1_000544

BRD-K93568044-001-03-1

BSPBio_000494

Balneol-hc

Barseb HC

Basan-Corti

Beta-hc

Bio-0648

Bioelements Immediate Comfort Hydrocortisone

Budpak Anti-itch

C00735

C21H30O5

CCRIS 5854

CHEBI:17650

CHEMBL389621

CID5754

COR-OTICIN

CPD000653523

CaldeCORT Spray

Caldecort

Care One Hydrocortisone maximum strength

Cetacort

Chronocort

Cicatricure Ultra Moisturizing

Clear aid

Cleiton

Cobadex

Colocort

Colocort (TN)

Compound F

Compound F (kendall)

Cor-Tar-Quin

Corhydron

Cort-Dome

Cort-Quin

Cortaid 12-hour Advanced Anti-Itch

Cortaid Intensive Therapy Cooling

Cortaid Maximum Strength

Cortanal

Cortef

Cortef (TN)

Cortenema

Cortesal

Corticreme

Cortifair

Cortifan

Cortifoam

Cortiment

Cortisol

Cortisol alcohol

Cortisol, Hydrocortisone

Cortisolonum

Cortisone

Cortisone Cream Intensive Healing

Cortisone Maximum Strength

Cortisone maximum strength

Cortisporin

Cortisporin Otico

Cortispray

Cortizol

Cortizone 10

Cortizone 10 Cooling Cream Anti-itch

Cortizone 10 Cooling Relief

Cortizone 10 Easy Relief

Cortizone 10 Hydratensive Healing Anti Itch

Cortizone 10 Hydratensive Soothing Anti Itch

Cortizone 10 Intensive Healing

Cortizone 10 Intensive Healing Feminine Itch Relief

Cortizone 10 Intensive Healing For Eczema

Cortizone 10 Plus

Cortizone 10 Poison Ivy Relief Pads

Cortolotion

Cortonema

Cortoxide

Cortril

Cremesone

Cremicort-H

Cutisol

Cvs Anti-itch Hydrocortisone

Cvs Cools Itch Fast

Cvs Cortisone

Cvs Pharmacy Anti-itch

Cyclodextrin-encapsulated hydrocortisone

D00088

DB00741

DB07886

Delacort

Derm-Aid

Dermacort

Dermacort Anti-Itch

Dermaquest Skin Therapy Post-skin Resurfacing Balm

Dermarest Eczema Medicated

Dermaspray

Dermil

Dermocortal

Dermolate

Dg Health Hydrocortisone

Dg Health Hydrocortisone Cream Maximum Strength

Dihydrocostisone

Dioderm

Dome-cort

Domolene-HC

Dr. Sheffield Hydrocortisone Anti Itch

Drotic

Duane Reade

Duane Reade hydrocortisone

Duane Reade hydrocortisone plus 12 moisturizers

DuoCort

EINECS 200-020-1

EU-0100594

Ef corlin

Efcorbin

Efcortelan

Efcortelin

Eldecort

Eldercort

Epicort

Epicortisol

Epiderm H

Equaline Anti Itch

Equaline Anti Itch maximum strength

Equate Hydrocortisone

Esiderm H

Evacort

Family Care Hydrocortisone

Family Wellness

Family Wellness Hydrocortisone

Family Wellness Maximum Strength Hydrocortisone

Ficortril

Fiocortril

Fixmyskin Healing Balm Fragrance-free

Fixmyskin Healing Balm Unflavored

Fixmyskin Healing Balm Vanilla Flavor

Fixmyskin Healing Balm Vanilla Fragrance

Flexicort

Foille Insetti

Formu Care Anti Itch maximum strength

Fulton Street Market Anti Itch

Genacort

Genacort (lotion)

Genuine Hydrocortisone

Glycort

Good Neighbor Pharmacy Anti Itch

Good Neighbor Pharmacy Hydrocortisone

Good Neighbor Pharmacy Hydrocortisone Plus 12 Moisturizers

Good Sense Anti Itch

Gyno-Cortisone

H 4001

H-Cort

H-releve Anti-itch

H0135_SIGMA

H0396_SIGMA

H0888_SIGMA

H3160_SIGMA

H4001_SIGMA

H6909_SIGMA

HC

HC #1

HC #4

HC (HYDROCORTISONE)

HMS1569I16

HMS2090M04

HSDB 3339

HYDROCORTISONE AND ACETIC ACID

HYDROCORTISONE IN ABSORBASE

Healerz For Itches

Health Mart Pharmacy Hydrocortisone Maximum Strength Plus 12 Moisturizers

Healthy Accents Cortisone maximum strength

Heb Cort

Heb-Cort

Hem-easy Relief Herbal Anti-itch Maximum Itch Relief

Hi-cor

Hidalone

Hidro-Colisona

Hidrocortisona

Hidrocortisona [INN-Spanish]

Hycort

Hycortol

Hycortole

Hydracort

Hydrasson

Hydro Skin

Hydro-Adreson

Hydro-Colisona

Hydro-RX

Hydro-colisona

Hydrocort

Hydrocortal

Hydrocorticosterone

Hydrocortisone

Hydrocortisone (JP15/USP/INN)

Hydrocortisone 1 plus 10

Hydrocortisone Acetate

Hydrocortisone Anti-itch Plus

Hydrocortisone Base

Hydrocortisone Butyrate

Hydrocortisone D

Hydrocortisone HC

Hydrocortisone Intensive Healing Formula

Hydrocortisone Maximum Strength

Hydrocortisone Maximum Strength Plus 12 Moisturizers

Hydrocortisone Plus

Hydrocortisone Plus 12 Moisturizers

Hydrocortisone Probutate

Hydrocortisone Regular Strength

Hydrocortisone Sodium Phosphate

Hydrocortisone Ultra Strength

Hydrocortisone Valerate

Hydrocortisone [INN:BAN:JAN]

Hydrocortisone alcohol

Hydrocortisone anti itch

Hydrocortisone base

Hydrocortisone free alcohol

Hydrocortisone maximum strength

Hydrocortisone solution

Hydrocortisone-Water Soluble

Hydrocortisonum

Hydrocortisonum [INN-Latin]

Hydrocortistab

Hydrocortisyl

Hydrocortone

Hydroskin

Hydroxycortisone

Hysone

Hytisone

Hytone

Hytone (TN)

Hytone lotion

Idrocortisone

Idrocortisone [DCIT]

Incortin-H

Incortin-hydrogen

Intensive Healing Anti Itch

Kaiser Permanente Hydrocortisone

Kendall'S compound F

Kendall's compound F

Kera Hc Hydrocortisone

Kirkland Signature Hydrocortisone Plus maximum strength

Komed HC

Kyypakkaus

LMST02030001

LS-7439

Lacticare HC

Lacticare-HC

Lactisona

Leader Hydrocortisone

Locoid

Loesch Anti-Itch Therapy

Lopac0_000594

Lubricort

Lucky Supersoft MAXIMUM STRENGTH

MLS000069609

MLS001148103

MLS002207135

MLS002222189

Maintasone

Makesense MAXIMUM STRENGTH

Maximum Strength Cortizone 10 Quick Shot 360 Continuous

Maximum Strength Hydrocortisone

Maximum-h

Medicort

Medpride

Meijer Anti Itch

Meijer Anti Itch Cream Plus

Meijer Hydrocortisone

Meijer Hydrocortisone Plus 12 Moisturizers

Members Mark Hydrocortisone

Meusicort

Mildison

Milliderm

MolPort-001-794-637

Monistat Complete Care Instant Itch Relief

NCGC00022848-06

NCGC00022848-07

NCGC00022848-09

NCGC00022848-12

NCI60_000118

NSC 10483

NSC-10483

NSC10483

Natureplex Hydrocortisone Hydro

Neo-Cort-Dome

Neo-Cortef

Neosporin Eczema Essentials Anti Itch

Neosporin-H Ear

Nogenic HC

Nu-derm Tolereen Anti-pruritic

Nutracort

Nystaform-HC

ORLEX HC

Optef

Otalgine

Otic-Neo-Cort-Dome

Otobiotic

Otocort

Otosone-F

Pandel

Pediaderm Hc

Pediotic Suspension

Penecort

Permicort

Piyanping Antiitch

Polcort H

Premier Value Hydrocortisone

Premier Value Hydrocortisone Plus 12 Moisturizers

Preparation H Hydrocortisone

Preparation H Hydrocortisone Cream

Prepcort

Prestwick0_000447

Prestwick1_000447

Prestwick2_000447

Prestwick3_000447

Prestwick_265

Prevex HC

Proactiv Solution Anti-itch Scalp

Procto-pak

Proctocort

Proctocream HC

Proctofoam

Proctosol-hc

Proctozone HC

Procure

Protocort

Publix Hydro

Publix hydro plus

Quadrydern

Quality Choice Hydrocortisone

Quality Choice Hydrocortisone Maximum Strength

Quality Choice Maximum Strength Anti Itch

Racet

Rectasol-HC

Rectoid

Refuge Hc

Reichstein'S substance M

Reichstein's substance M

Remederm HC

Rexall Anti Itch maximum strength relief

Rexall Hydrocortisone 1

Rexall Hydrocortisone plus moisturizers

Rite Aid anti-itch

S1696_Selleck

SAM002264617

SMP1_000156

SMR000059022

SMR000653523

SPBio_002433

Safeway Hydrocortisone Plus 12 Moisturizers

Sanatison

Scalp-Cort

Scalpicin Anti-Itch Maximum Strength

Scalpicin Capilar

Scalpicin Maximum Strength

Scalpicin Scalp Itch Medication Maximum Strength

Schericur

Scheroson F

Shopko Hydrocortisone

Shopko Hydrocortisone Intensive Healing Formula

Shopko Hydrocortisone Maximum Strength

Shopko Hydrocortisone Plus 12 Moisturizers Maximum Strength

Shopko Maximum Strength

Shoprite Hydrocortisone

Sigmacort

Signef

Smart Sense Anti Itch

Smart Sense Anti Itch maximum strength

Smart Sense Hydrocortisone

Solu-cortef

Soothe Rodan Fields

Stie-cort

Stiefcorcil

Sunmark Hydrocortisone

Sunmark Hydrocortisone Plus 12 Moisturizers

Synacort

Systral Hydrocort

Tarcortin

Tecnu Corticool

Texacort

Texacort lotion 25

Thera Plus

Timocort

Topcare Hydrocortisone

Topcare Hydrocortisone Intensive Healing Formula

Topcare Hydrocortisone Plus 12 Moisturizers

Topicort

Transderma H

Traumaide

Truelipids Anti-itch Barrier

U-cort

UNII-WI4X0X7BPJ

UPCMLD-DP133

UPCMLD-DP133:001

Uniderm

Vioform-Hydrocortisone

VoSol HC

Vytone

Walgreens Hydrocortisone Plus 12 Moisturizers

Westcort

Western Family HydroCortisone

Western Family HydroCortisone Plus 12 Moisturizers

Zenoxone

[3H]cortisol

component of Lubricort

component of Neo-Cort-Dome

component of Otalgine

hydrocortisone

22

Ribavirin

approved

Phase 2

948

36791-04-5

37542

Synonyms:

1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide

1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide

1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide

1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide

36791-04-5

437710-49-1

66510-90-5

AA-504/07617051

AB00430481

AC1L1XXZ

AC1Q1IDC

AC1Q4ZGS

AKOS001715163

BB_NC-0567

BPBio1_001195

BRN 0892462

BSPBio_001085

BSPBio_003352

C-Virin

CHEMBL1643

CID37542

Copegus

Copegus (TN)

Cotronak

D00423

DB00811

DRG-0028

DivK1c_000782

Drug: Ribavirin

EU-0101063

FT-0082885

HMS2090L15

HMS2094O09

HMS502H04

HSDB 6513

ICN-1229

IDI1_000782

Ibavyr

KBio1_000782

KBio2_002328

KBio2_004896

KBio2_007464

KBio3_002854

KBioGR_001804

KBioSS_002331

KS-1104

LS-1241

Lopac0_001063

MLS000028486

MLS002222317

Moderiba

MolPort-002-507-104

MolPort-002-885-856

NCGC00090726-01

NCGC00090726-03

NCGC00090726-04

NCGC00090726-05

NCGC00090726-06

NCGC00090726-07

NINDS_000782

NSC 163039

NSC163039

Prestwick3_000993

R 9644

R-964

R9644_SIGMA

RBV

RG-964

RIBAV

RTC

RTCA

RTP

Ravanex

Rebetol

Rebetol (TN)

Rebetron

Rebretron

Ribacine

Ribamide

Ribamidil

Ribamidyl

Ribasphere

Ribasphere (TN)

Ribasphere Ribapak

Ribav

Ribavirin

Ribavirin (JAN/USP/INN)

Ribavirin Capsules

Ribavirin Triphosphate

Ribavirin [USAN:INN]

Ribavirin-TP

Ribavirina

Ribavirina [INN-Spanish]

Ribavirine

Ribavirine [INN-French]

Ribavirinum

Ribavirinum [INN-Latin]

Ribovirin

Ro 20-9963/000

Ro-20-9963

S2504_Selleck

SCH 18908

SMP1_000261

SMR000058315

SPECTRUM1503938

SR-01000076112-3

Spectrum3_001876

Spectrum4_001252

Spectrum5_002075

Spectrum_001826

Tribavirin

UNII-49717AWG6K

Varazid

Vilona

Viramid

Viramide

Virazid

Virazide

Virazole

Virazole (Ribavirin) Inhalation Solution

Virazole (TN)

Virazole 5'-triphosphate

ZINC01035331

ribavirin

23

chloroquine

approved

Phase 1, Phase 2

141

54-05-7

2719

Synonyms:

( -)-Chloroquine

(+)-Chloroquine

(-)-Chloroquine

(R)-(-)-Chloroquine

3377 RP opalate

3545-67-3

50-63-5

54-05-7

56598-66-4

58175-86-3

58175-87-4

7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline

7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline

AB00053436

AC1L1EB8

AC1Q2ZA7

AC1Q2ZA8

Amokin

Aralen

Aralen HCl

Arechin

Arechine

Arequin

Arolen

Arthrochin

Artrichin

Avlochlor

Avloclor

BPBio1_000655

BRD-A91699651-065-01-1

BRN 0482809

BSPBio_000595

BSPBio_002001

Bemaco

Bemaphate

Bemasulph

Benaquin

Bipiquin

C07625

C18H26ClN3

CCRIS 3439

CHEBI:3638

CHEMBL76

CID2719

CQ

CU-01000012392-2

Capquin

Chemochin

Chingamin

Chloraquine

Chlorochin

Chlorochine

Chlorochinum

Chloroin

Chloroquin

Chloroquina

Chloroquine

Chloroquine (USP/INN)

Chloroquine (VAN)

Chloroquine Bis-Phosphoric Acid

Chloroquine Phosphate

Chloroquine [USAN:INN:BAN]

Chloroquine phosphate

Chloroquinium

Chloroquinum

Chloroquinum [INN-Latin]

Chlorquin

Cidanchin

Clorochina

Clorochina [DCIT]

Cloroquina

Cloroquina [INN-Spanish]

Cocartrit

D02366

DB00608

Dawaquin

Delagil

Dichinalex

DivK1c_000404

EINECS 200-191-2

Elestol

Gontochin

Gontochin phosphate

HMS2090O03

HSDB 3029

Heliopar

Hydroxychloroquine Sulfate

IDI1_000404

Imagon

Ipsen 225

Iroquine

KBio1_000404

KBio2_000592

KBio2_003160

KBio2_005728

KBio3_001221

KBioGR_000778

KBioSS_000592

Khingamin

Klorokin

LS-141726

Lapaquin

Lopac0_000296

Malaquin

Malaquin (*Diphosphate*)

Malaren

Malarex

Mesylith

Miniquine

MolMap_000009

MolPort-001-783-623

N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine

N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine

N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine

NCGC00015256-04

NCGC00162120-01

NCI60_000894

NINDS_000404

NSC 187208

NSC14050

NSC187208

Neochin

Nivachine

Nivaquine

Nivaquine B

Nivaquine b

Pfizerquine

Plaquenil

Prestwick0_000548

Prestwick1_000548

Prestwick2_000548

Prestwick3_000548

Quinachlor

Quinagamin

Quinagamine

Quinercyl

Quingamine

Quinilon

Quinoscan

RP 3377

RP-3377

Resochen

Resochin

Resoquina

Resoquine

Reumachlor

Reumaquin

Rivoquine

Ro 01-6014/N2

Ronaquine

Roquine

SMP2_000034

SN 6718

SN-7618

SPBio_000174

SPBio_002516

ST 21

ST 21 (pharmaceutical)

Sanoquin

Silbesan

Siragan

Solprina

Sopaquin

Spectrum2_000127

Spectrum3_000341

Spectrum4_000279

Spectrum5_000707

Spectrum_000132

Tanakan

Tanakene

Tresochin

Trochin

UNII-886U3H6UFF

W 7618

WIN 244

WLN: T66 BNJ EMY1&3N2&2 IG

chloroquine

nchembio.215-comp4

nchembio.368-comp8

nchembio.87-comp17

{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine

24

Coagulants

Phase 2

1042

25

Antibodies

Phase 1, Phase 2

4477

26

Immunoglobulins

Phase 1, Phase 2

4477

27

Hemostatics

Phase 2

1082

28

Hydrocortisone-17-butyrate

Phase 2

583

29

Hydrocortisone acetate

Phase 2

583

30

Hydrocortisone 17-butyrate 21-propionate

Phase 2

583

31

Antimetabolites

Phase 2

9454

32

Antiviral Agents

Phase 2

8071

33

Cortisol succinate

Phase 2

583

34

Antirheumatic Agents

Phase 1, Phase 2

8496

35

Peripheral Nervous System Agents

Phase 1, Phase 2

18510

36

Antiprotozoal Agents

Phase 1, Phase 2

1730

37

Chloroquine diphosphate

Phase 1, Phase 2

141

50-63-5

38

Anti-Inflammatory Agents

Phase 1, Phase 2

8478

39

Analgesics

Phase 1, Phase 2

9358

40

Analgesics, Non-Narcotic

Phase 1, Phase 2

5184

41

Anthelmintics

Phase 1, Phase 2

379

42

Anti-Inflammatory Agents, Non-Steroidal

Phase 1, Phase 2

3549

43

Antimalarials

Phase 1, Phase 2

1058

44

Aluminum hydroxide

approved

Phase 1

178

Synonyms:

Al(OH)3

Aluminiumhydroxid

Aluminum Hydroxide

Aluminum hydroxide

Dermadrox

45

Gastrointestinal Agents

Phase 1

6401

46

Anti-Ulcer Agents

Phase 1

1453

47

Antacids

Phase 1

1453

48

Adjuvants, Immunologic

Phase 1

1783

49

Aluminum sulfate

Phase 1

79

50

Papaya

Nutraceutical

Phase 1

15

Interventional clinical trials:

(show top 50) (show all 136)

id	Name	Status	NCT ID	Phase
1	Ketotifen as a Treatment for Vascular Leakage During Dengue Fever	Recruiting	NCT02673840	Phase 4
2	Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)	Not yet recruiting	NCT02555072	Phase 4
3	Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia	Completed	NCT01134263	Phase 3
4	Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers	Completed	NCT01436396	Phase 3
5	Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers	Completed	NCT01411241	Phase 3
6	Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia	Completed	NCT01254422	Phase 3
7	Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine	Recruiting	NCT02406729	Phase 3
8	Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children	Recruiting	NCT02747927	Phase 3
9	Efficacy and Safety of Ivermectin Against Dengue Infection	Recruiting	NCT02045069	Phase 2, Phase 3
10	Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR	Recruiting	NCT00938379	Phase 3
11	Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia	Active, not recruiting	NCT01373281	Phase 3
12	Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America	Active, not recruiting	NCT01374516	Phase 3
13	Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)	Active, not recruiting	NCT00966628	Phase 3
14	Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine	Completed	NCT01488890	Phase 2
15	A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines	Completed	NCT01064141	Phase 2
16	Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India	Completed	NCT01550289	Phase 2
17	Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America	Completed	NCT00993447	Phase 2
18	Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore	Completed	NCT00880893	Phase 2
19	Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America	Completed	NCT01187433	Phase 2
20	A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants	Completed	NCT00322049	Phase 1, Phase 2
21	Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects	Completed	NCT00730288	Phase 2
22	A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children	Completed	NCT00384670	Phase 1, Phase 2
23	Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects	Completed	NCT00875524	Phase 2
24	Efficacy and Safety of Dengue Vaccine in Healthy Children	Completed	NCT00842530	Phase 2
25	Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US	Completed	NCT00617344	Phase 2
26	Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults	Completed	NCT00740155	Phase 2
27	Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years	Completed	NCT00788151	Phase 2
28	A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children	Completed	NCT01843621	Phase 1, Phase 2
29	A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults	Completed	NCT00239577	Phase 2
30	A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children	Completed	NCT00468858	Phase 2
31	Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia	Completed	NCT01218906	Phase 2
32	A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults	Completed	NCT00350337	Phase 2
33	A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand	Completed	NCT00370682	Phase 2
34	Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)	Completed	NCT02193087	Phase 2
35	Celgosivir as a Treatment Against Dengue	Completed	NCT01619969	Phase 1, Phase 2
36	Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever	Completed	NCT01601613	Phase 2
37	The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans	Completed	NCT01943305	Phase 2
38	Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age	Recruiting	NCT02628444	Phase 2
39	Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule	Recruiting	NCT02623725	Phase 2
40	Safety and Immunogenicity With Two Different Serotype 2 Potencies of Tetravalent Dengue Vaccine (TDV) in Adults in Singapore	Recruiting	NCT02425098	Phase 2
41	Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults	Recruiting	NCT02421367	Phase 1, Phase 2
42	Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand	Recruiting	NCT02332733	Phase 2
43	Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms	Recruiting	NCT01973855	Phase 2
44	Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine	Active, not recruiting	NCT01943825	Phase 2
45	Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine	Active, not recruiting	NCT01696422	Phase 2
46	Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants	Active, not recruiting	NCT02302066	Phase 2
47	Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years	Active, not recruiting	NCT01511250	Phase 2
48	The Effect of Chloroquine in the Treatment of Patients With Dengue	Active, not recruiting	NCT00849602	Phase 1, Phase 2
49	Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults	Not yet recruiting	NCT02741128	Phase 2
50	Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh	Not yet recruiting	NCT02678455	Phase 2

Search NIH Clinical Center for Dengue Disease

Cochrane evidence based reviews: dengue

Genetic Tests for Dengue Disease

Anatomical Context for Dengue Disease

Sources:
³³MalaCards
See all MalaCards sources

MalaCards organs/tissues related to Dengue Disease:

³³

Eye, Bone, Skin, Kidney, Liver, T cells, Testes

Animal Models for Dengue Disease or affiliated genes

Sources:
³⁸MGI
See all MalaCards sources

MGI Mouse Phenotypes related to Dengue Disease:

³⁸

id	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hematopoietic system	MP:0005397	7.0	CCL5, CD40LG, ICAM1, MBL2, MRC1, PIK3C2A
2	immune system	MP:0005387	6.7	CCL5, CD40LG, ICAM1, MBL2, MRC1, PIK3C2A

Publications for Dengue Disease

Sources:
⁵⁴PubMed
See all MalaCards sources

Articles related to Dengue Disease:

(show top 50) (show all 81)

id	Title	Authors	Year
1	Seasonal Distribution and Climatic Correlates of Dengue Disease in Dhaka, Bangladesh. (27114293)	Morales I.... Gurley E.S.	2016
2	Clinical and laboratory signs associated to severe dengue disease in hospitalized children. (27112034)	Pone S.M.... Brasil P.	2016
3	Mannose-binding lectin gene (MBL2) polymorphisms related to the mannose-binding lectin low levels are associated to dengue disease severity. (27180198)	Figueiredo G.G.... Moura P.	2016
4	High prevalence of clinically unsuspected dengue disease among children in Ribeirao Preto City, Brazil. (27004990)	Poloni T.R.... Aquino V.H.	2016
5	Epidemiological and demographic characteristics of dengue disease at a tertiary care centre in Saurashtra region during the year 2013. (26714509)	Mistry M.... Thakkar D.	2015
6	Antibody-enhanced dengue disease generates a marked CNS inflammatory response in the black-tufted marmoset Callithrix penicillata. (26303046)	Vasconcelos B.C.... Diniz D.G.	2015
7	Biomarkers of severe dengue disease - a review. (26462910)	John D.V.... Perng G.C.	2015
8	Antibodies against immature virions are not a discriminating factor for dengue disease severity. (25760350)	Rodenhuis-Zybert I.A.... Smit J.M.	2015
9	Dengue Disease Risk Mental Models in the City of Dhaka, Bangladesh: Juxtapositions and Gaps Between the Public and Experts. (26387980)	Dhar-Chowdhury P.... Driedger S.M.	2015
10	Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. (26220099)	Flingai S.... Weiner D.B.	2015
11	Evolution of dengue disease and entomological monitoring in Santa Cruz, Bolivia 2002 - 2008. (25706631)	BrAcmond P.... Vargas J.	2015
12	CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. (25217165)	Zellweger R.M.... Shresta S.	2014
13	Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of CearA!, Brazil. (24626308)	Cavalcanti L.P.... MourALo M.P.	2014
14	Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. (25375162)	DantAcs H.G.... Sarti E.	2014
15	Dengue disease surveillance: an updated systematic literature review. (24889501)	Runge-Ranzinger S.... Horstick O.	2014
16	Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. (24216294)	Soundravally R.... Kumar B.A.	2014
17	Epidemiology of Dengue Disease in the Philippines (2000-2011): A Systematic Literature Review. (25375119)	Bravo L.... L'Azou M.	2014
18	First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. (24699622)	Ng J.K.... Alonso S.	2014
19	Dengue disease outbreak detection. (25160360)	Dayama P.... Sampath K.	2014
20	Predictive symptoms and signs of severe dengue disease for patients with dengue fever: a meta-analysis. (25097856)	Zhang H.... Chen X.G.	2014
21	Dengue disease surveillance: improving data for dengue control. (25375232)	Horstick O.... Morrison A.C.	2014
22	Epidemiology of dengue disease in malaysia (2000-2012): a systematic literature review. (25375211)	Mohd-Zaki A.H.... L'Azou M.	2014
23	Dogma in classifying dengue disease. (23926138)	Farrar J.J.... Wills B.A.	2013
24	Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. (24386496)	Teixeira M.G.... Joint G.	2013
25	The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis. (23476150)	Sun P.... Kochel T.J.	2013
26	Knowledge, attitude, and practice of dengue disease among healthcare professionals in southern Taiwan. (23332425)	Ho T.S.... Liu C.C.	2013
27	An optimal control problem arising from a dengue disease transmission model. (23274179)	Aldila D.... Soewono E.	2013
28	Atypical presentations of dengue disease in the elderly visiting the ED. (23399333)	Lee C.C.... Ko W.C.	2013
29	Comment on: "Atypical presentations of dengue disease in the elderly visiting the ED" (24342867)	Arya S.C.... Agarwal N.	2013
30	Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses. (22383925)	Falconar A.K.... Romero-Vivas C.M.	2012
31	Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity. (20858223)	Paradkar P.N.... Vasudevan S.G.	2011
32	Biosensors and rapid diagnostic tests on the frontier between analytical and clinical chemistry for biomolecular diagnosis of dengue disease: a review. (21241843)	Teles F.S.	2011
33	Virus role during intraepidemic increase in dengue disease severity. (21254883)	Rodriguez-Roche R.... Guzman M.G.	2011
34	Evaluation of the traditional and revised WHO classifications of Dengue disease severity. (22087348)	Narvaez F.... Harris E.	2011
35	Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. (21502191)	Lin Y.S.... Lei H.Y.	2011
36	Characterization of early host responses in adults with dengue disease. (21810247)	Tolfvenstam T.... Hibberd M.L.	2011
37	Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. (21811645)	Duong V.... Buchy P.	2011
38	Markers of dengue disease severity. (19802579)	Srikiatkhachorn A.... Green S.	2010
39	Characteristic of dengue disease in Taiwan: 2002-2007. (20348527)	Lin C.C.... Lei H.Y.	2010
40	A BALB/c mouse model shows that liver involvement in dengue disease is immune-mediated. (20673760)	FranAsa R.F.... da Fonseca B.A.	2010
41	Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. (20153282)	Zellweger R.M.... Shresta S.	2010
42	Understanding the contribution of cellular immunity to dengue disease pathogenesis. (18837790)	Mathew A.... Rothman A.L.	2008
43	Blood group AB is associated with increased risk for severe dengue disease in secondary infections. (17330792)	Kalayanarooj S.... Perng G.C.	2007
44	NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. (16412060)	Azeredo E.L.... Kubelka C.F.	2006
45	Relationship of thrombopoietin and interleukin-11 levels to thrombocytopenia associated with dengue disease. (16759877)	Cardier J.E.... Rothman A.L.	2006
46	Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. (12641411)	Nisalak A.... Vaughn D.W.	2003
47	Immunology and immunopathogenesis of dengue disease. (14689699)	Rothman A.L.	2003
48	Dengue disease spectrum among infants in the 2001 dengue epidemic in Chennai, Tamil Nadu, India. (12904418)	Kabilan L.... Satyanarayana K.	2003
49	A model for dengue disease with variable human population. (10220925)	Esteva L.... Vargas C.	1999
50	Analysis of a dengue disease transmission model. (9656647)	Esteva L.... Vargas C.	1998

Genes related to Dengue Disease

Sources:
²⁰GeneCards, ¹²DISEASES, ⁴⁷Novoseek
See all MalaCards sources

Genes related to Dengue Disease:

(show all 15)

- Elite gene

- Cancer Census gene in COSMIC

id	Symbol	Description	Score	Implication	PubmedIds
1	CD209	CD209 Molecule	32.15	DISEASES inferred ¹² Novoseek inferred ⁴⁷ GeneCards inferred via : Publications (show sections)	12682107, 19941667, 16417930 more 19264337, 16239964, 15855154, 18593570, 16274635, 17005819, 18167547, 16469696
2	CD40LG	CD40 Ligand	25.72	DISEASES inferred ¹² Novoseek inferred ⁴⁷	9431954, 19478396, 19858464 more 10973453, 14607869, 16914345, 11063489, 10391862, 15525913, 12853395, 17715330, 1297178, 12626461, 15956408, 9242317, 9646004, 12873179, 15184425, 16385170, 17898184, 10348250, 18940116, 10973469, 10572311, 9749624, 20089524, 19755928, 17257502, 9606000, 11724841, 9817913, 10473522, 17889487, 15498040, 17056582, 9455871, 9574674, 16210489, 9650956
3	ICAM1	Intercellular Adhesion Molecule 1	22.14	DISEASES inferred ¹² GeneCards inferred via : Publications (show sections)
4	VCAM1	Vascular Cell Adhesion Molecule 1	21.92	DISEASES inferred ¹² GeneCards inferred via : Publications (show sections)
5	CCL5	C-C Motif Chemokine Ligand 5	20.02	DISEASES inferred ¹² Novoseek inferred ⁴⁷	11022000, 17416433, 15122797 more 16103156, 19837110
6	SULT1A3	Sulfotransferase Family 1A Member 3	18.44	DISEASES inferred ¹² Novoseek inferred ⁴⁷	17006283
7	PTPN11	Protein Tyrosine Phosphatase, Non-Receptor Type 11	17.57	Novoseek inferred ⁴⁷	10928995, 12436482, 2149144 more 1849979, 18052531, 9191856, 12355369, 9268170, 19232866, 19592650, 18679379, 17319166, 9130232, 18788905, 19822367, 17329445, 2063952, 16122850, 16544248
8	THPO	Thrombopoietin	17.44	GeneCards inferred via : Publications (show sections)
9	MBL2	Mannose Binding Lectin 2	17.44	GeneCards inferred via : Publications (show sections)
10	MRC1	Mannose Receptor, C Type 1	17.18	DISEASES inferred ¹² ¹²
11	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	16.70	DISEASES inferred ¹²
12	HCFC1	Host Cell Factor C1	16.56	Novoseek inferred ⁴⁷	9649218, 11335136
13	IVNS1ABP	Influenza Virus NS1A Binding Protein	10.26	Novoseek inferred ⁴⁷	10698995, 11825945, 12853395 more 18471994, 9158059, 15184425, 18279077, 16140430, 15780810, 18439289, 16891505, 19122918, 19733994, 19264772, 16894199, 18685015, 19232392, 16103191, 18288598, 18714359, 17958746, 11596093, 19478848, 17653458
14	SENP8	SUMO/Sentrin Peptidase Family Member, NEDD8 Specific	9.82	DISEASES inferred ¹²
15	PIK3C2A	Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Alpha	8.12	DISEASES inferred ¹² Novoseek inferred ⁴⁷	8274073, 10191585

Variations for Dengue Disease

Expression for genes affiliated with Dengue Disease

Sources:
¹⁷Gene Expression Omnibus DataSets, ³²LifeMap Discovery®
See all MalaCards sources

Genes differentially expressed in tissues of Dengue Disease patients vs. healthy controls: ³² (show all 93)

id	Gene	Description	Tissue	Up/Dn	Fold Change (log2)	P value
1	IFI27	interferon, alpha-inducible protein 27	Blood	+	4.85	0.000
2	RRM2	ribonucleotide reductase M2	Blood	+	4.48	0.000
3	CEP55	centrosomal protein 55kDa	Blood	+	4.33	0.000
4	BIRC5	baculoviral IAP repeat containing 5	Blood	+	4.30	0.000
5	XIST	X inactive specific transcript (non-protein coding)	Blood	-	4.25	0.009
6	CD38	CD38 molecule	Blood	+	4.23	0.000
7	DLGAP5	discs, large (Drosophila) homolog-associated protein 5	Blood	+	4.10	0.000
8	BUB1	BUB1 mitotic checkpoint serine/threonine kinase	Blood	+	4.08	0.000
9	IGHM	immunoglobulin heavy constant mu	Blood	+	4.04	0.000
10	MCM10	minichromosome maintenance 10 replication initiation factor	Blood	+	3.99	0.000
11	SHCBP1	SHC SH2-domain binding protein 1	Blood	+	3.97	0.000
12	PBK	PDZ binding kinase	Blood	+	3.97	0.000
13	TYMS	thymidylate synthetase	Blood	+	3.96	0.000
14	PI3	peptidase inhibitor 3, skin-derived	Blood	-	3.93	0.000
15	CDCA2	cell division cycle associated 2	Blood	+	3.91	0.000
16	SESN3	sestrin 3	Blood	-	3.90	0.000
17	HMMR	hyaluronan-mediated motility receptor (RHAMM)	Blood	+	3.83	0.000
18	MKI67	marker of proliferation Ki-67	Blood	+	3.83	0.000
19	ZWINT	ZW10 interacting kinetochore protein	Blood	+	3.83	0.000
20	DTL	denticleless E3 ubiquitin protein ligase homolog (Drosophila)	Blood	+	3.80	0.000
21	CDK1	cyclin-dependent kinase 1	Blood	+	3.78	0.000
22	NCAPG	non-SMC condensin I complex, subunit G	Blood	+	3.76	0.000
23	CDT1	chromatin licensing and DNA replication factor 1	Blood	+	3.76	0.000
24	SPC25	SPC25, NDC80 kinetochore complex component	Blood	+	3.75	0.000
25	CDC20	cell division cycle 20	Blood	+	3.73	0.000
26	CNTNAP3	contactin associated protein-like 3	Blood	-	3.72	0.000
27	TOP2A	topoisomerase (DNA) II alpha	Blood	+	3.71	0.000
28	NOV	nephroblastoma overexpressed	Blood	-	3.71	0.000
29	EIF1AY	eukaryotic translation initiation factor 1A, Y-linked	Blood	+	3.69	0.015
30	CCNB2	cyclin B2	Blood	+	3.62	0.000
31	CDKN3	cyclin-dependent kinase inhibitor 3	Blood	+	3.62	0.000
32	KIAA0101	KIAA0101	Blood	+	3.61	0.000
33	KIF2C	kinesin family member 2C	Blood	+	3.60	0.000
34	TK1	thymidine kinase 1, soluble	Blood	+	3.59	0.000
35	RPS4Y1	ribosomal protein S4, Y-linked 1	Blood	+	3.57	0.017
36	TTK	TTK protein kinase	Blood	+	3.56	0.000
37	CDC6	cell division cycle 6	Blood	+	3.56	0.000
38	CAV1	caveolin 1, caveolae protein, 22kDa	Blood	+	3.56	0.000
39	CENPA	centromere protein A	Blood	+	3.54	0.000
40	CYAT1	immunoglobulin lambda light chain-like	Blood	+	3.52	0.000
41	ASPM	abnormal spindle microtubule assembly	Blood	+	3.52	0.000
42	OR2W3	olfactory receptor, family 2, subfamily W, member 3	Blood	-	3.51	0.000
43	UHRF1	ubiquitin-like with PHD and ring finger domains 1	Blood	+	3.50	0.000
44	SELENBP1	selenium binding protein 1	Blood	-	3.50	0.000
45	GINS2	GINS complex subunit 2 (Psf2 homolog)	Blood	+	3.49	0.000
46	MELK	maternal embryonic leucine zipper kinase	Blood	+	3.47	0.000
47	BUB1B	BUB1 mitotic checkpoint serine/threonine kinase B	Blood	+	3.47	0.000
48	CHEK1	checkpoint kinase 1	Blood	+	3.46	0.000
49	CCNB1	cyclin B1	Blood	+	3.45	0.000
50	KIF11	kinesin family member 11	Blood	+	3.42	0.000
51	E2F8	E2F transcription factor 8	Blood	+	3.41	0.000
52	CCNA2	cyclin A2	Blood	+	3.40	0.000
53	KCTD14	potassium channel tetramerization domain containing 14	Blood	+	3.40	0.000
54	IGL	immunoglobulin lambda locus	Blood	+	3.37	0.000
55	IGLJ3	immunoglobulin lambda joining 3	Blood	+	3.35	0.000
56	CDCA5	cell division cycle associated 5	Blood	+	3.31	0.000
57	TPX2	TPX2, microtubule-associated	Blood	+	3.31	0.000
58	KIF20A	kinesin family member 20A	Blood	+	3.30	0.000
59	E2F7	E2F transcription factor 7	Blood	+	3.28	0.000
60	ANLN	anillin actin binding protein	Blood	+	3.28	0.000
61	KDM5D	lysine (K)-specific demethylase 5D	Blood	+	3.28	0.017
62	JAZF1	JAZF zinc finger 1	Blood	-	3.27	0.000
63	HJURP	Holliday junction recognition protein	Blood	+	3.25	0.000
64	IGKV3-20	immunoglobulin kappa variable 3-20	Blood	+	3.24	0.000
65	KIF4A	kinesin family member 4A	Blood	+	3.22	0.000
66	KIF15	kinesin family member 15	Blood	+	3.20	0.000
67	CNTNAP3B	contactin associated protein-like 3B	Blood	-	3.19	0.000
68	TNFRSF17	tumor necrosis factor receptor superfamily, member 17	Blood	+	3.19	0.000
69	AURKB	aurora kinase B	Blood	+	3.18	0.000
70	TRIP13	thyroid hormone receptor interactor 13	Blood	+	3.18	0.000
71	CCND2	cyclin D2	Blood	+	3.17	0.000
72	GINS1	GINS complex subunit 1 (Psf1 homolog)	Blood	+	3.16	0.000
73	IGLV2-23	immunoglobulin lambda variable 2-23	Blood	+	3.15	0.000
74	SLC6A8	solute carrier family 6 (neurotransmitter transporter), member 8	Blood	-	3.15	0.000
75	KIF18B	kinesin family member 18B	Blood	+	3.14	0.000
76	OIP5	Opa interacting protein 5	Blood	+	3.14	0.000
77	KRT1	keratin 1, type II	Blood	-	3.12	0.001
78	GGH	gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)	Blood	+	3.11	0.000
79	RAD51	RAD51 recombinase	Blood	+	3.10	0.000
80	GLDC	glycine dehydrogenase (decarboxylating)	Blood	+	3.10	0.000
81	RAD51AP1	RAD51 associated protein 1	Blood	+	3.09	0.000
82	DDX3Y	DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked	Blood	+	3.09	0.028
83	MBNL3	muscleblind-like splicing regulator 3	Blood	-	3.09	0.000
84	IGLV1-44	immunoglobulin lambda variable 1-44	Blood	+	3.09	0.000
85	MCM4	minichromosome maintenance complex component 4	Blood	+	3.08	0.000
86	IGLV4-60	immunoglobulin lambda variable 4-60	Blood	+	3.08	0.000
87	FOXM1	forkhead box M1	Blood	+	3.06	0.000
88	ESPL1	extra spindle pole bodies like 1, separase	Blood	+	3.06	0.000
89	SLC4A1	solute carrier family 4 (anion exchanger), member 1 (Diego blood group)	Blood	-	3.05	0.000
90	IGLV3-19	immunoglobulin lambda variable 3-19	Blood	+	3.04	0.000
91	GTSE1	G-2 and S-phase expressed 1	Blood	+	3.04	0.000
92	PDZK1IP1	PDZK1 interacting protein 1	Blood	-	3.02	0.000
93	USP18	ubiquitin specific peptidase 18	Blood	+	3.00	0.000

Search GEO for disease gene expression data for Dengue Disease.

Pathways for genes affiliated with Dengue Disease

Sources:
⁵²PathCards, ⁵⁵QIAGEN, ⁵⁷Reactome, ³¹KEGG, ⁵⁶R&D Systems, ³⁹NCBI BioSystems Database, ⁶²Thomson Reuters
See all MalaCards sources

Pathways related to Dengue Disease according to GeneCards Suite gene sharing:

(show all 13)

id	Super pathways	Score	Top Affiliating Genes
1	LDL Oxidation in Atherogenesis⁵⁵	10.0	ICAM1, VCAM1
2	CD209 (DC-SIGN) signaling⁵⁷	9.8	CD209, RAF1
3	NF-kappa B signaling pathway³¹	9.7	CD40LG, ICAM1, VCAM1
4	Cell adhesion molecules (CAMs)³¹	9.7	CD40LG, ICAM1, VCAM1
5	IgA-Producing B Cells in the Intestine⁵⁶	9.7	CD40LG, ICAM1, VCAM1
6	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell⁵⁷	9.7	CD40LG, ICAM1, VCAM1
7	Malaria³¹	9.7	CD40LG, ICAM1, VCAM1
8	TNF signaling pathway³¹	9.7	CCL5, ICAM1, VCAM1
9	Interleukin-11 Signaling Pathway³⁹	9.4	ICAM1, PTPN11, RAF1
10	IL-5 Signaling Pathway³⁹	9.4	ICAM1, PTPN11, RAF1
11	Development VEGF signaling via VEGFR2 - generic cascades⁶² Show member pathways Development VEGF signaling and activation⁶² VEGF - VEGF R2 Signaling Pathways⁵⁶	9.2	ICAM1, PTPN11, RAF1, VCAM1
12	Immune response_Role of integrins in NK cells cytotoxicity⁶²	9.2	ICAM1, PTPN11, RAF1, VCAM1
13	Influenza A³¹ Show member pathways Herpes simplex infection³¹ Measles³¹	7.8	CCL5, CD209, HCFC1, ICAM1, IVNS1ABP, PTPN11

GO Terms for genes affiliated with Dengue Disease

Sources:
¹⁸Gene Ontology
See all MalaCards sources

Biological processes related to Dengue Disease according to GeneCards Suite gene sharing:

id	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of T cell proliferation	GO:0042102	10.3	CCL5, VCAM1
2	leukocyte cell-cell adhesion	GO:0007159	9.8	CCL5, CD40LG, ICAM1, VCAM1
3	interferon-gamma-mediated signaling pathway	GO:0060333	9.6	ICAM1, PTPN11, VCAM1
4	platelet activation	GO:0030168	9.4	CD40LG, RAF1, THPO